SCC
EIDX

Spring Creek Capital’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Spring Creek Capital’s Portfolio EIDX Stock Details EIDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-140,000
Closed -$18.4M – 450
2020
Q4 		$18.4M Buy
+140,000
New +$18.4M 1.35% 17